SEC Form 4
STERIS plc (STE) insider trading
In the 12 months to Nov 15, 2026, 8 STE insiders reported open-market sales of $8.6M across 9 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $8.6M
- 9 filings · 8 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 2 of 9
- $1.2M of $8.6M sold (14%)
Who traded STE, and when
- Sale
- Sale, pre-arranged (10b5-1)
STE daily close from Nov 17, 2025 to Nov 13, 2026, between $199.40 and $268.65, last $264.32. 9 sale and 0 purchase filings by 8 insiders, marked at their filing dates. Mohsen Sohi, Director: sold $2.2M across 2 filings, first filed Aug 12, 2026, last Nov 12, 2026. Karen L. Burton, Sr. Vice Pres., CFO: sold $1.5M across 1 filing, first filed Nov 12, 2026, last Nov 12, 2026. Julia Madsen, Sr. VP and GM, Life Sciences: sold $1.3M across 1 filing, first filed Nov 25, 2025, last Nov 25, 2025. Renato Tamaro, V.P. & Corporate Treasurer: sold $1.3M across 1 filing, first filed Nov 20, 2025, last Nov 20, 2025. Daniel A. Carestio, President and CEO: sold $946.8K across 1 filing, first filed Jun 8, 2026, last Jun 8, 2026. Cynthia L. Feldmann, Director: sold $734.9K across 1 filing, first filed Mar 6, 2026, last Mar 6, 2026. 2 others: sold $607.3K across 2 filings, first filed Jun 4, 2026, last Jun 16, 2026.
Largest mark · tap a row for others
Karen L. Burton · Sr. Vice Pres., CFO
Sale $1,503,046
5,880 shares
Filed Nov 12, 2026 · traded Nov 11
Close on filing date $253.44
Mohsen Sohi · Director
Director
$2.2M soldKaren L. Burton · Sr. Vice Pres., CFO
Sr. Vice Pres., CFO
$1.5M soldJulia Madsen · Sr. VP and GM, Life Sciences
Sr. VP and GM, Life Sciences
$1.3M soldRenato Tamaro · V.P. & Corporate Treasurer
V.P. & Corporate Treasurer
$1.3M soldDaniel A. Carestio · President and CEO
President and CEO
$946.8K soldCynthia L. Feldmann · Director
Director
$734.9K sold2 others
Combined, one mark per week
$607.3K soldOpen-market trades
9 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Mohsen Sohi | Director | $2.2M | — | 2 | — | |
| Karen L. Burton | Sr. Vice Pres., CFO | $1.5M | — | 1 | — | |
| Julia Madsen | Sr. VP and GM, Life Sciences | $1.3M | — | 1 | — | |
| Renato Tamaro | V.P. & Corporate Treasurer | $1.3M | — | 1 | — | |
| Daniel A. Carestio | President and CEO | $946.8K | — | 1 | 100% of sales | |
| Cynthia L. Feldmann | Director | $734.9K | — | 1 | — | |
| Richard C. Breeden | Director | $310.3K | — | 1 | — | |
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | $297.0K | — | 1 | 100% of sales |
| Filed | Insider | Type | Shares | Value | Held after | Source |
|---|---|---|---|---|---|---|
traded | Mohsen Sohi Director | Sale | 4,893 ordinary shares | $1.2M | 25,970 | |
traded | Karen L. Burton Sr. Vice Pres., CFO | Sale | 5,880 ordinary shares | $1.5M | 12,956 | |
traded | Mohsen Sohi Director | Sale | 4,058 ordinary shares | $956.8K | 24,305 | |
traded | John Adam Zangerle Sr. VP, Gen Counsel, and Sec. | SalePre-arranged (10b5-1) | 1,419 ordinary shares | $297.0K | 35,259 | |
traded | Daniel A. Carestio President and CEO | SalePre-arranged (10b5-1) | 4,428 ordinary shares | $946.8K | 63,647 | |
traded | Richard C. Breeden Director | Sale | 1,481 ordinary shares | $310.3K | 38,964 | |
traded | Cynthia L. Feldmann Director | Sale | 3,098 ordinary shares | $734.9K | 705 | |
traded | Julia Madsen Sr. VP and GM, Life Sciences | Sale | 5,008 ordinary shares | $1.3M | 10,710 | |
traded | Renato Tamaro V.P. & Corporate Treasurer | Sale | 5,036 ordinary shares | $1.3M | 7,407 |
Shares are as filed (ordinary shares or ADS); values are as converted to US$ in the filing.
GET /stocks/filings/vX/form-4?tickers=STE&filing_date.gte=2025-11-15&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"STE"
],
"issuer_cik": "0001757898",
"owner_cik": "0001293588",
"accession_number": "0001628280-26-073442",
"form_type": "4",
"filing_date": "2026-11-12",
"period_of_report": "2026-11-10",
"issuer_name": "STERIS plc",
"issuer_trading_symbol": "STE",
"owner_name": "Sohi Mohsen",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-10",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1665,
"transaction_price_per_share": 253.9,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 24305,
"transaction_value": 422743.5,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."
}
]
},
{
"tickers": [
"STE"
],
"issuer_cik": "0001757898",
"owner_cik": "0001697095",
"accession_number": "0001628280-26-073444",
"form_type": "4",
"filing_date": "2026-11-12",
"period_of_report": "2026-11-11",
"issuer_name": "STERIS plc",
"issuer_trading_symbol": "STE",
"owner_name": "Burton Karen L",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Sr. Vice Pres., CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-11",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 5880,
"transaction_price_per_share": 255.62,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 12956,
"transaction_value": 1503045.6,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."
},
{
"id": "F2",
"description": "As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 53 records
- Option exercises10 records
- Tax withholding33 records
- Grants and awards10 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has STERIS plc's CEO sold stock?
Yes. Daniel A. Carestio (CEO) sold 4,428 shares ($946.8K) in Jun 2026, all under a pre-arranged 10b5-1 plan.
How current is STE’s insider data?
These are STE Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track STE insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for STE every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.